Time to Progression Ratio in Cancer Patients Enrolled in Early Phase Clinical Trials: Time for New Guidelines?

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0245-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

Validation of Prognostic Scoring and Assessment of Clinical Benefit for Patients With Bone Sarcomas Enrolled in Phase I Clinical Trials

Oncotarget
Oncology
2016English

Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer

Cancer
Cancer ResearchOncology
2010English

Analysis of Esophagogastric Cancer Patients Enrolled in the National Cancer Institute Cancer Therapy Evaluation Program Sponsored Phase 1 Trials

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2016English

Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients With Cancer Over Time

Oncologist
Cancer ResearchMedicineOncology
2019English

Is It Time to Conduct Phase 3 Clinical Trials of Sex Hormones in MS – Commentary

Multiple Sclerosis
Neurology
2018English

Progression-Free Survival Decreases With Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials

Journal of Cancer
Oncology
2012English

Guidelines for Clinical Trials

Journal of Orthopaedic and Sports Physical Therapy
MedicinePhysical TherapySports TherapyRehabilitationSports Science
1995English

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy